<?xml version="1.0" encoding="UTF-8"?>
<p>2019-nCoV gene encodes 4 structural proteins: S, E, M and N. These proteins include multiple epitopes (
 <xref rid="b58-etm-0-0-09142" ref-type="bibr">58</xref>). Using the principle of specific binding of antigens to antibodies, antibodies can be used to detect the presence of antigens, thereby directly detecting whether samples contain 2019-nCoV (
 <xref rid="b59-etm-0-0-09142" ref-type="bibr">59</xref>). The applicable sample type of the antigen detection reagent is generally an infection site sample, such as a throat swab. Currently, several research teams have developed a variety of antigen detection kits, which are awaiting approval from the State Drug Administration (
 <xref rid="tVI-etm-0-0-09142" ref-type="table">Table VI</xref>) (
 <xref rid="b22-etm-0-0-09142" ref-type="bibr">22</xref>).
</p>
